Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Temozolomide, and when can generic versions of Temozolomide launch?

Temozolomide is a drug marketed by Rising Pharms Inc, Idt Australia Ltd, Mylan Pharms Inc, Accord Hlthcare, Chemi Spa, Sun Pharma Global, Deva Holding As, Watson Labs Teva, Barr, Amerigen Pharms Ltd, Amneal Pharms, and Kremers Urban Pharms. and is included in twelve NDAs.

The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the temozolomide profile page.

Summary for Tradename: TEMOZOLOMIDE

Suppliers / Packagers: see list13
Bulk Api Vendors: see list85
Clinical Trials: see list275
Patent Applications: see list7,011
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TEMOZOLOMIDE at DailyMed

Pharmacology for Tradename: TEMOZOLOMIDE

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deva Holding As
CAPSULE;ORAL207658-005Apr 26, 2017ABRXNoNo► Subscribe► Subscribe
Sun Pharma Global
CAPSULE;ORAL201742-002Feb 12, 2014ABRXNoNo► Subscribe► Subscribe
CAPSULE;ORAL078879-002Mar 1, 2010ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
CAPSULE;ORAL203691-001May 8, 2015ABRXNoNo► Subscribe► Subscribe
Watson Labs Teva
CAPSULE;ORAL203959-003Apr 18, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus